One burns what's there, the other changes the trajectory, burning fat instead of storing it
BPC-157 / TB-500 is a co-lyophilized research blend combining a synthetic pentadecapeptide (BPC-157) and a thymosin beta-4 fragment (TB-500) in a fixed 1:1 ratio, commonly referenced in scientific literature for dual-pathway studies investigating angiogenic signaling and cytoskeletal reorganization
The regenerative and protective actions of GHK-Cu make it a key player in maintaining overall cellular health
What Is the Best Time of Day to Use GHK-Cu
Nakamura K, Ikeuchi T, Nara K, Rhodes CS, Zhang P, Chiba Y, et al
A typical TB-500 cycle involves loading doses of 4 to 8mg weekly for the first 4 to 6 weeks, then maintenance doses of 2 to 4mg weekly thereafter